Although a higher number of mutations in the inhA and/or katG genes would be expected due to those detected in rpoB (considering that resistance to RIF is a marker of MDR-TB), the findings show a decrease in strains with mutations in both drugs (4, 15). The gene discussed is INHA; the disease is tuberculosis.